Publications by authors named "Xavier B Pivot"

Claim this Profile
T
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Edith A Perez, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Xavier B Pivot

Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
Edith A Perez, Sanne Lysbet de Haas, Wolfgang Eiermann, Carlos H Barrios, Masakazu Toi, Xavier B Pivot

BMC Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
Edith A Perez, Sanne Lysbet de Haas, Wolfgang Eiermann, Carlos H Barrios, Masakazu Toi, Xavier B Pivot

BMC Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey.
Sébastien Couraud, Alexis B Cortot, Xavier B Pivot, Chantal Touboul, Christine Lhomel

Prev Med Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians.
Jean-François Morère, Jérôme Viguier, Sébastien Couraud, Lysel Brignoli-Guibaudet, Christine Lhomel, Xavier B Pivot

Curr Oncol Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.
Joseph Gligorov, Xavier B Pivot, William Jacot, Hervé L Naman, Dominique Spaeth

Oncologist· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.
Gabriel N Hortobagyi, Henry L Gomez, Rubi K Li, Hyun-Cheol Chung, Luis E Fein, Xavier B Pivot

Breast Cancer Res Treat· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer.
Xavier B Pivot, Rubi K Li, Eva S Thomas, Hyun-Cheol Chung, Luis E Fein

Eur J Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
Eva S Thomas, Henry L Gomez, Rubi K Li, Hyun-Cheol Chung, Luis E Fein, Xavier B Pivot

J Clin Oncol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis